-
She writes on how the health care system causes Black people to “live sicker and die quicker” compared white people. In this interview, she talks about how to tackle racial disparities in health care.
-
Amendment 3 could help end an era of discriminatory enforcement, according to some proponents, elected officials and drug experts. How and whether it will is a growing question.
-
The SisterSong Women of Color Reproductive Justice Collective centers its mission on maternal health with its Birth Justice Care Fund, which provides doula care, maternal mental health therapy and baby supplies.
-
Research suggests repeated exposure to stressors, such as racism and discrimination, leads to poor health outcomes among Black Americans. In Part 1 of this special series "The Price of Pain: Black Health & Reparations in America," we explore the effects of racial weathering.
-
A biased test kept thousands of Black people from getting a kidney transplant. It's finally changingThe U.S. transplant system ordered hospitals to quit using a test that made Black patients' kidneys appear healthier than they really were.
-
A novel program in Tennessee aims to interest more Black and other minority medical students in organ transplants, to help ease troubling disparities.
-
After the Supreme Court struck down affirmative action in college admissions, concerns have arisen that a pathway into medicine may become much harder for students of color. Heightening the alarm: the medical field’s reckoning with longstanding health inequities.
-
Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month.
-
Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners — products with little regulatory oversight — may pose cancer and other health risks.
-
Minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.